Duration of rubella immunity induced by two-dose measles, mumps and rubella (MMR) vaccination. A 15-year follow-up in Finland

This publication has 29 references indexed in Scilit:

• No measles in Finland
  The Lancet, 1997
• Immunity to rubella before and after vaccination against measles, mumps and rubella (MMR) at 12 years of age of the first generation offered MMR vaccination in Sweden at 18 months
  Vaccine, 1995
• The Elimination of Indigenous Measles, Mumps, and Rubella from Finland by a 12-Year, Two-Dose Vaccination Program
  New England Journal of Medicine, 1994
• Long-term follow-up study of rubella antibodies in naturally immune and vaccinated young adults
  Vaccine, 1994
• Rubella antibody persistence after immunization. Sixteen-year follow-up in the Hawaiian Islands
  JAMA, 1988
• RAPID EFFECT ON ENDEMIC MEASLES, MUMPS, AND RUBELLA OF NATIONWIDE VACCINATION PROGRAMME IN FINLAND
  The Lancet, 1986
• Duration of Immunity After Rubella Vaccination: A Long-Term Study in Switzerland
  Clinical Infectious Diseases, 1985
• Persistence of rubella antibodies 15 years after subcutaneous administration of Wistar 27/3 strain live attenuated rubella virus vaccine
  Vaccine, 1984
• Persistence of rubella antibody 8-18 years after vaccination.
  BMJ, 1984
• Rubella antibody persistence after immunization
  Published by American Medical Association (AMA) ,1982